Chronic wounds are characterized by their inability to heal within an expected time frame and have emerged as an increasingly important clinical problem over the past several decades, owing to their increasing incidence and greater recognition of associated morbidity and socio-economic burden. Even up to a few years ago, the management of chronic wounds relied on standards of care that were outdated. However, the approach to these chronic conditions has improved, with better prevention, diagnosis and treatment. Such improvements are due to major advances in understanding of cellular and molecular aspects of basic science, in innovative and technological breakthroughs in treatment modalities from biomedical engineering, and in our ability to conduct well-controlled and reliable clinical research. The evidence-based approaches resulting from these advances have become the new standard of care. At the same time, these improvements are tempered by the recognition that persistent gaps exist in scientific knowledge of impaired healing and the ability of clinicians to reduce morbidity, loss of limb and mortality. Therefore, taking stock of what is known and what is needed to improve understanding of chronic wounds and their associated failure to heal is crucial to ensuring better treatments and outcomes.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $79.00 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Frykberg, R. G. & Banks, J. Challenges in the treatment of chronic wounds. Adv. Wound Care 4, 560–582 (2015).
Lazarus, G. S. et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch. Dermatol. 130, 489–493 (1994).
Sen, C. K. et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair. Regen. 17, 763–771 (2009).
Janowska, A. et al. Atypical ulcers: diagnosis and management. Clin. Interv. Aging 14, 2137–2143 (2019).
Sen, C. K. Human wound and its burden: updated 2020 compendium of estimates. Adv. Wound Care 10, 281–292 (2021).
Martinengo, L. et al. Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies. Ann. Epidemiol. 29, 8–15 (2019).
Olsson, M. et al. The humanistic and economic burden of chronic wounds: a systematic review. Wound Repair Regen. 27, 114–125 (2019).
Lim, H. W. et al. The burden of skin disease in the United States. J. Am. Acad. Dermatol. 76, 958–972.e2 (2017).
Hall, J. et al. Point prevalence of complex wounds in a defined United Kingdom population. Wound Repair Regen. 22, 694–700 (2014).
Margolis, D. J., Bilker, W., Knauss, J., Baumgarten, M. & Strom, B. L. The incidence and prevalence of pressure ulcers among elderly patients in general medical practice. Ann. Epidemiol. 12, 321–325 (2002).
Margolis, D. J. et al. Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care 34, 2363–2367 (2011).
Margolis, D. J. & Jeffcoate, W. Epidemiology of foot ulceration and amputation: can global variation be explained? Med. Clin. North. Am. 97, 791–805 (2013).
Fletcher, J. Measuring the prevalence and incidence of chronic wounds. Prof. Nurse 18, 384–388 (2003).
Mervis, J. S. & Phillips, T. J. Pressure ulcers: prevention and management. J. Am. Acad. Dermatol. 81, 893–902 (2019).
Courvoisier, D. S., Righi, L., Bene, N., Rae, A. C. & Chopard, P. Variation in pressure ulcer prevalence and prevention in nursing homes: a multicenter study. Appl. Nurs. Res. 42, 45–50 (2018).
Anthony, D., Alosoumi, D. & Safari, R. Prevalence of pressure ulcers in long-term care: a global review. J. Wound Care 28, 702–709 (2019).
Lopes, T. S., Videira, L., Saraiva, D., Agostinho, E. S. & Bandarra, A. J. F. Multicentre study of pressure ulcer point prevalence in a Portuguese region. J. Tissue Viability 29, 12–18 (2020).
Diaz-Herrera, M. A. et al. Multicentre study of chronic wounds point prevalence in primary health care in the southern metropolitan area of Barcelona. J. Clin. Med. 10, 797 (2021).
Wei, M. et al. The prevalence and prevention of pressure ulcers: a multicenter study of nine nursing homes in eastern China. J. Tissue Viability 30, 133–136 (2021).
Baumgarten, M. et al. Risk factors for pressure ulcers among elderly hip fracture patients. Wound Repair. Regen. 11, 96–103 (2003).
Baumgarten, M. et al. Extrinsic risk factors for pressure ulcers early in the hospital stay: a nested case-control study. J. Gerontol. A Biol. Sci. Med. Sci. 63, 408–413 (2008).
Nelson, E. A. & Adderley, U. Venous leg ulcers. BMJ Clin. Evid. 2016, 1902 (2016).
Margolis, D. J., Bilker, W., Santanna, J. & Baumgarten, M. Venous leg ulcer: incidence and prevalence in the elderly. J. Am. Acad. Dermatol. 46, 381–386 (2002).
Homs-Romero, E. et al. Validity of chronic venous disease diagnoses and epidemiology using validated electronic health records from primary care: a real-world data analysis. J. Nurs. Scholarsh. 53, 296–305 (2021).
Forssgren, A., Fransson, I. & Nelzen, O. Leg ulcer point prevalence can be decreased by broad-scale intervention: a follow-up cross-sectional study of a defined geographical population. Acta Derm. Venereol. 88, 252–256 (2008).
Berenguer Perez, M., Lopez-Casanova, P., Sarabia Lavin, R., Gonzalez de la Torre, H. & Verdu-Soriano, J. Epidemiology of venous leg ulcers in primary health care: Incidence and prevalence in a health centre — a time series study (2010-2014). Int. Wound J. 16, 256–265 (2019).
Walsh, J. W., Hoffstad, O. J., Sullivan, M. O. & Margolis, D. J. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet. Med. 33, 1493–1498 (2016).
Hoffstad, O., Mitra, N., Walsh, J. & Margolis, D. J. Diabetes, lower-extremity amputation, and death. Diabetes Care 38, 1852–1857 (2015).
Margolis, D. J., Hofstad, O. & Feldman, H. I. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care 31, 1331–1336 (2008).
Heyer, K., Herberger, K., Protz, K., Glaeske, G. & Augustin, M. Epidemiology of chronic wounds in Germany: analysis of statutory health insurance data. Wound Repair Regen. 24, 434–442 (2016).
Graves, N. How costs change with infection prevention efforts. Curr. Opin. Infect. Dis. 27, 390–393 (2014).
Malay, D. S., Margolis, D. J., Hoffstad, O. J. & Bellamy, S. The incidence and risks of failure to heal after lower extremity amputation for the treatment of diabetic neuropathic foot ulcer. J. Foot Ankle Surg. 45, 366–374 (2006).
Margolis, D. et al. Prevelance of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006–2008, Rockville, MD (Agency for Healthcare Research and Quality, 2010).
Holman, N., Young, R. J. & Jeffcoate, W. J. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 55, 1919–1925 (2012).
Margolis, D. J., Gelfand, J. M., Hoffstad, O. & Berlin, J. A. Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 26, 1696–1700 (2003).
Margolis, D. J., Kantor, J., Santanna, J., Strom, B. L. & Berlin, J. A. Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch. Dermatol. 136, 1531–1535 (2000).
Margolis, D. J., Allen-Taylor, L., Hoffstad, O. & Berlin, J. A. Healing diabetic neuropathic foot ulcers: are we getting better? Diabet. Med. 22, 172–176 (2005).
Rodrigues, M., Kosaric, N., Bonham, C. A. & Gurtner, G. C. Wound healing: a cellular perspective. Physiol. Rev. 99, 665–706 (2019).
Falanga, V. Wound healing and its impairment in the diabetic foot. Lancet 366, 1736–1743 (2005).
Eming, S. A., Martin, P. & Tomic-Canic, M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci. Transl. Med. 6, 265sr6 (2014).
Zindle, J. K., Wolinsky, E. & Bogie, K. M. A review of animal models from 2015 to 2020 for preclinical chronic wounds relevant to human health. J. Tissue Viability 30, 291–300 (2021).
Falanga, V. et al. Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen. 12, 320–326 (2004).
Nunan, R., Harding, K. G. & Martin, P. Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity. Dis. Model. Mech. 7, 1205–1213 (2014).
Grada, A., Mervis, J. & Falanga, V. Research techniques made simple: animal models of wound healing. J. Invest. Dermatol. 138, 2095–2105.e1 (2018).
Elliot, S., Wikramanayake, T. C., Jozic, I. & Tomic-Canic, M. A modeling conundrum: murine models for cutaneous wound healing. J. Invest. Dermatol. 138, 736–740 (2018).
Ahn, S. T. & Mustoe, T. A. Effects of ischemia on ulcer wound healing: a new model in the rabbit ear. Ann. Plast. Surg. 24, 17–23 (1990).
Buck, D. W. 2nd et al. The TallyHo polygenic mouse model of diabetes: implications in wound healing. Plast. Reconstr. Surg. 128, 427e–437e (2011).
Davis, S. C. & Mertz, P. M. Determining the effect of an oak bark formulation on methicillin-resistant Staphylococcus aureus and wound healing in porcine wound models. Ostomy Wound Manag. 54, 16–18, 20, 22–25 (2008).
Dhall, S. et al. Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters. J. Diabetes Res. 2014, 562625 (2014).
Eaglstein, W. H. & Mertz, P. M. New methods for assessing epidermal wound healing: the effects of triamcinolone acetonide and polyethelene film occlusion. J. Invest. Dermatol. 71, 382–384 (1978).
Fadini, G. P. et al. NETosis delays diabetic wound healing in mice and humans. Diabetes 65, 1061–1071 (2016).
Olson, H. M. & Nechiporuk, A. V. Using zebrafish to study collective cell migration in development and disease. Front. Cell Dev. Biol. 6, 83 (2018).
Seaton, M., Hocking, A. & Gibran, N. S. Porcine models of cutaneous wound healing. ILAR J. 56, 127–138 (2015).
Stone, R.II, Wall, J. T., Natesan, S. & Christy, R. J. PEG-plasma hydrogels increase epithelialization using a human ex vivo skin model. Int. J. Mol. Sci. 19, 3156 (2018).
Arenas Gomez, C. M., Sabin, K. Z. & Echeverri, K. Wound healing across the animal kingdom: crosstalk between the immune system and the extracellular matrix. Dev. Dyn. 249, 834–846 (2020).
MacLeod, A. S. & Mansbridge, J. N. The innate immune system in acute and chronic wounds. Adv. Wound Care 5, 65–78 (2016).
Weavers, H. & Martin, P. The cell biology of inflammation: from common traits to remarkable immunological adaptations. J. Cell. Biol. 219, e202004003 (2020).
Nguyen, A. V. & Soulika, A. M. The dynamics of the skin’s immune system. Int. J. Mol. Sci. 20, 1811 (2019).
Nestle, F. O., Di Meglio, P., Qin, J. Z. & Nickoloff, B. J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679–691 (2009).
Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).
Dasu, M. R. & Isseroff, R. R. Toll-like receptors in wound healing: location, accessibility, and timing. J. Invest. Dermatol. 132, 1955–1958 (2012).
Kirchner, S., Lei, V. & MacLeod, A. S. The cutaneous wound innate immunological microenvironment. Int. J. Mol. Sci. 21, 8748 (2020).
Wilgus, T. A. Alerting the body to tissue injury: the role of alarmins and DAMPs in cutaneous wound healing. Curr. Pathobiol. Rep. 6, 55–60 (2018).
Nelson, A. M. et al. dsRNA released by tissue damage activates TLR3 to drive skin regeneration. Cell Stem Cell 17, 139–151 (2015).
Borkowski, A. W., Park, K., Uchida, Y. & Gallo, R. L. Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation, and epidermal organelles. J. Invest. Dermatol. 133, 2031–2040 (2013).
Mangoni, M. L., McDermott, A. M. & Zasloff, M. Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp. Dermatol. 25, 167–173 (2016).
Strbo, N., Yin, N. & Stojadinovic, O. Innate and adaptive immune responses in wound epithelialization. Adv. Wound Care 3, 492–501 (2014).
Gronberg, A., Mahlapuu, M., Stahle, M., Whately-Smith, C. & Rollman, O. Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial. Wound Repair Regen. 22, 613–621 (2014).
Heilborn, J. D. et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379–389 (2003).
Li, D. et al. Single-cell analysis reveals major histocompatibility complex II expressing keratinocytes in pressure ulcers with worse healing outcomes. J. Investig. Dermatol. 142, 705–716 (2022).
Shook, B. A. et al. Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science 362, eaar2971 (2018).
Plikus, M. V. et al. Regeneration of fat cells from myofibroblasts during wound healing. Science 355, 748–752 (2017).
desJardins-Park, H. E., Foster, D. S. & Longaker, M. T. Fibroblasts and wound healing: an update. Regen. Med. 13, 491–495 (2018).
Foster, D. S., Jones, R. E., Ransom, R. C., Longaker, M. T. & Norton, J. A. The evolving relationship of wound healing and tumor stroma. JCI Insight 3, e99911 (2018).
Jones, R. E., Foster, D. S. & Longaker, M. T. Management of chronic wounds — 2018. JAMA 320, 1481–1482 (2018).
Theocharidis, G. et al. Single cell transcriptomic landscape of diabetic foot ulcers. Nat. Commun. 13, 181 (2022).
Mascharak, S. et al. Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science 372, eaba2374 (2021).
Januszyk, M. et al. Characterization of diabetic and non-diabetic foot ulcers using single-cell RNA-sequencing. Micromachines 11, 815 (2020).
Krzyszczyk, P., Schloss, R., Palmer, A. & Berthiaume, F. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front. Physiol. 9, 419 (2018).
Hesketh, M., Sahin, K. B., West, Z. E. & Murray, R. Z. Macrophage phenotypes regulate scar formation and chronic wound healing. Int. J. Mol. Sci. 18, 1545 (2017).
Nahrendorf, M. & Swirski, F. K. Abandoning M1/M2 for a network model of macrophage function. Circ. Res. 119, 414–417 (2016).
Minutti, C. M., Knipper, J. A., Allen, J. E. & Zaiss, D. M. Tissue-specific contribution of macrophages to wound healing. Semin. Cell Dev. Biol. 61, 3–11 (2017).
Kratofil, R. M., Kubes, P. & Deniset, J. F. Monocyte conversion during inflammation and injury. Arterioscler. Thromb. Vasc. Biol. 37, 35–42 (2017).
Lucas, T. et al. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184, 3964–3977 (2010).
Shook, B., Xiao, E., Kumamoto, Y., Iwasaki, A. & Horsley, V. CD301b+ macrophages are essential for effective skin wound healing. J. Investig. Dermatol. 136, 1885–1891 (2016).
Pang, J., Maienschein-Cline, M. & Koh, T. J. Enhanced proliferation of Ly6C(+) monocytes/macrophages contributes to chronic inflammation in skin wounds of diabetic mice. J. Immunol. 206, 621–630 (2021).
Kim, S. Y. & Nair, M. G. Macrophages in wound healing: activation and plasticity. Immunol. Cell Biol. 97, 258–267 (2019).
Kimball, A. S. et al. The histone methyltransferase Setdb2 modulates macrophage phenotype and uric acid production in diabetic wound repair. Immunity 51, 258–271.e5 (2019).
Aloysius, A., Saxena, S. & Seifert, A. W. Metabolic regulation of innate immune cell phenotypes during wound repair and regeneration. Curr. Opin. Immunol. 68, 72–82 (2021).
Eming, S. A., Wynn, T. A. & Martin, P. Inflammation and metabolism in tissue repair and regeneration. Science 356, 1026–1030 (2017).
Bodnar, E. et al. Redox profiling reveals clear differences between molecular patterns of wound fluids from acute and chronic wounds. Oxid. Med. Cell Longev. 2018, 5286785 (2018).
Szondi, D. C., Wong, J. K., Vardy, L. A. & Cruickshank, S. M. Arginase signalling as a key player in chronic wound pathophysiology and healing. Front. Mol. Biosci. 8, 773866 (2021).
Jetten, N. et al. Wound administration of M2-polarized macrophages does not improve murine cutaneous healing responses. PLoS ONE 9, e102994 (2014).
Dreymueller, D., Denecke, B., Ludwig, A. & Jahnen-Dechent, W. Embryonic stem cell-derived M2-like macrophages delay cutaneous wound healing. Wound Repair Regen. 21, 44–54 (2013).
Sawaya, A. P. et al. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat. Commun. 11, 4678 (2020).
Spiller, K. L. & Koh, T. J. Macrophage-based therapeutic strategies in regenerative medicine. Adv. Drug Deliv. Rev. 122, 74–83 (2017).
Nassiri, S., Zakeri, I., Weingarten, M. S. & Spiller, K. L. Relative expression of proinflammatory and antiinflammatory genes reveals differences between healing and nonhealing human chronic diabetic foot ulcers. J. Investig. Dermatol. 135, 1700–1703 (2015).
Gould, L. et al. Chronic wound repair and healing in older adults: current status and future research. J. Am. Geriatr. Soc. 63, 427–438 (2015).
Kaplan, D. H. Ontogeny and function of murine epidermal Langerhans cells. Nat. Immunol. 18, 1068–1075 (2017).
Joshi, N. et al. Comprehensive characterization of myeloid cells during wound healing in healthy and healing-impaired diabetic mice. Eur. J. Immunol. 50, 1335–1349 (2020).
Stojadinovic, O. et al. Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome. Immunol. Res. 57, 222–228 (2013).
Rajesh, A. et al. Depletion of langerin(+) cells enhances cutaneous wound healing. Immunology 160, 366–381 (2020).
Grotendorst, G. R., Smale, G. & Pencev, D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J. Cell Physiol. 140, 396–402 (1989).
Peiseler, M. & Kubes, P. More friend than foe: the emerging role of neutrophils in tissue repair. J. Clin. Investig. 129, 2629–2639 (2019).
Phillipson, M. & Kubes, P. The healing power of neutrophils. Trends Immunol. 40, 635–647 (2019).
Wilgus, T. A., Roy, S. & McDaniel, J. C. Neutrophils and wound repair: positive actions and negative reactions. Adv. Wound Care 2, 379–388 (2013).
Wang, J. Neutrophils in tissue injury and repair. Cell Tissue Res. 371, 531–539 (2018).
Wong, S. L. et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat. Med. 21, 815–819 (2015).
Pollenus, E. et al. Limitations of neutrophil depletion by anti-Ly6G antibodies in two heterogenic immunological models. Immunol. Lett. 212, 30–36 (2019).
Devalaraja, R. M. et al. Delayed wound healing in CXCR2 knockout mice. J. Investig. Dermatol. 115, 234–244 (2000).
Kienle, K. & Lammermann, T. Neutrophil swarming: an essential process of the neutrophil tissue response. Immunol. Rev. 273, 76–93 (2016).
Papayannopoulos, V. & Zychlinsky, A. NETs: a new strategy for using old weapons. Trends Immunol. 30, 513–521 (2009).
Deniset, J. F. & Kubes, P. Recent advances in understanding neutrophils. F1000Res. 5, 2912 (2016).
Gong, Y. & Koh, D. R. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 339, 437–448 (2010).
Mukai, K., Tsai, M., Saito, H. & Galli, S. J. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol. Rev. 282, 121–150 (2018).
Tellechea, A. et al. Mast cells regulate wound healing in diabetes. Diabetes 65, 2006–2019 (2016).
Wilgus, T. A., Ud-Din, S. & Bayat, A. A review of the evidence for and against a role for mast cells in cutaneous scarring and fibrosis. Int. J. Mol. Sci. 21, 9673 (2020).
Havran, W. L. & Jameson, J. M. Epidermal T cells and wound healing. J. Immunol. 184, 5423–5428 (2010).
MacLeod, A. S. et al. Dendritic epidermal T cells regulate skin antimicrobial barrier function. J. Clin. Invest. 123, 4364–4374 (2013).
Jameson, J. et al. A role for skin gammadelta T cells in wound repair. Science 296, 747–749 (2002).
Li, Y. et al. Vgamma4 T cells inhibit the pro-healing functions of dendritic epidermal T cells to delay skin wound closure through IL-17A. Front. Immunol. 9, 240 (2018).
Taylor, K. R., Mills, R. E., Costanzo, A. E. & Jameson, J. M. Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease. PLoS ONE 5, e11422 (2010).
Mathur, A. N. et al. Treg-cell control of a CXCL5-IL-17 inflammatory axis promotes hair-follicle-stem-cell differentiation during skin-barrier repair. Immunity 50, 655–667 e4 (2019).
Nosbaum, A. et al. Cutting edge: regulatory T cells facilitate cutaneous wound healing. J. Immunol. 196, 2010–2014 (2016).
Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015).
Laurent, P. et al. Immune-mediated repair: a matter of plasticity. Front. Immunol. 8, 454 (2017).
Kroeze, K. L. et al. Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. J. Invest. Dermatol. 132, 216–225 (2012).
Johnson, B. Z., Stevenson, A. W., Prele, C. M., Fear, M. W. & Wood, F. M. The role of IL-6 in skin fibrosis and cutaneous wound healing. Biomedicines 8, 101 (2020).
Gushiken, L. F. S., Beserra, F. P., Bastos, J. K., Jackson, C. J. & Pellizzon, C. H. Cutaneous wound healing: an update from physiopathology to current therapies. Life 11, 665 (2021).
Wolcott, R., Costerton, J. W., Raoult, D. & Cutler, S. J. The polymicrobial nature of biofilm infection. Clin. Microbiol. Infect. 19, 107–112 (2013).
Schultz, G. et al. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds. Wound Repair Regen. 25, 744–757 (2017).
Granick, M., Boykin, J., Gamelli, R., Schultz, G. & Tenenhaus, M. Toward a common language: surgical wound bed preparation and debridement. Wound Repair Regen. 14 (Suppl. 1), S1–S10 (2006).
Versey, Z. et al. Biofilm-innate immune interface: contribution to chronic wound formation. Front. Immunol. 12, 648554 (2021).
Kovacs, A. T. & Dragos, A. Evolved biofilm: review on the experimental evolution studies of Bacillus subtilis pellicles. J. Mol. Biol. 431, 4749–4759 (2019).
Ram, M. et al. Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats. Eur. J. Pharmacol. 764, 9–21 (2015).
Tchanque-Fossuo, C. N., Dahle, S. E., Buchman, S. R. & Isseroff, R. R. Deferoxamine: potential novel topical therapeutic for chronic wounds. Br. J. Dermatol. 176, 1056–1059 (2017).
Bonham, C. A., Kuehlmann, B. & Gurtner, G. C. Impaired neovascularization in aging. Adv. Wound Care 9, 111–126 (2020).
DeFrates, K. G., Franco, D., Heber-Katz, E. & Messersmith, P. B. Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling. Biomaterials 269, 120646 (2021).
US National Library of Medicine. ClinicalTrials.gov https://www.clinicaltrials.gov/ct2/show/NCT03137966 (2022).
Duscher, D. et al. Optimization of transdermal deferoxamine leads to enhanced efficacy in healing skin wounds. J. Control. Rel. 308, 232–239 (2019).
US National Library of Medicine. ClinicalTrials.gov https://www.clinicaltrials.gov/ct2/show/NCT04058197 (2021).
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
Zhang, L., Stokes, N., Polak, L. & Fuchs, E. Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell 8, 294–308 (2011).
Hildebrand, J. et al. A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J. Invest. Dermatol. 131, 20–29 (2011).
Banerjee, J. & Sen, C. K. microRNA and wound healing. Adv. Exp. Med. Biol. 888, 291–305 (2015).
Li, D. et al. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J. Clin. Invest. 125, 3008–3026 (2015).
Herter, E. K. & Xu Landen, N. Non-coding RNAs: new players in skin wound healing. Adv. Wound Care 6, 93–107 (2017).
Mori, R., Tanaka, K. & Shimokawa, I. Identification and functional analysis of inflammation-related miRNAs in skin wound repair. Dev. Growth Differ. 60, 306–315 (2018).
Yang, X. et al. miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int. J. Biol. Sci. 7, 685–690 (2011).
Li, C. X. et al. MicroRNA-21 preserves the fibrotic mechanical memory of mesenchymal stem cells. Nat. Mater. 16, 379–389 (2017).
Pastar, I. et al. Induction of specific microRNAs inhibits cutaneous wound healing. J. Biol. Chem. 287, 29324–29335 (2012).
Vanden Oever, M., Muldoon, D., Mathews, W., McElmurry, R. & Tolar, J. miR-29 regulates type VII collagen in recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 136, 2013–2021 (2016).
Suh, E. J. et al. A microRNA network regulates proliferative timing and extracellular matrix synthesis during cellular quiescence in fibroblasts. Genome Biol. 13, R121 (2012).
Li, B. et al. Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer. FASEB J. 35, e20526 (2021).
Auler, M. et al. miR-127-3p is an epigenetic activator of myofibroblast senescence situated within the microRNA-enriched Dlk1-Dio3Imprinted domain on mouse chromosome 12. J. Invest. Dermatol. 141, 1076–1086 e3 (2021).
Liu, P., Zhu, Y., Li, Q. & Cheng, B. Comprehensive analysis of differentially expressed miRNAs and mRNAs reveals that miR-181a-5p plays a key role in diabetic dermal fibroblasts. J. Diabetes Res. 2020, 4581954 (2020).
Biswas, S. et al. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc. Natl Acad. Sci. USA 107, 6976–6981 (2010).
Li, X. et al. MicroRNA-132 with therapeutic potential in chronic wounds. J. Invest. Dermatol. 137, 2630–2638 (2017).
Naqvi, R. A., Gupta, M., George, A. & Naqvi, A. R. MicroRNAs in shaping the resolution phase of inflammation. Semin. Cell Dev. Biol. 124, 48 (2022).
Zhai, X. et al. Bibliometric analysis of global scientific research on lncRNA: a swiftly expanding trend. Biomed. Res. Int. 2018, 7625078 (2018).
Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231–235 (2013).
Kretz, M. et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 26, 338–343 (2012).
Herter, E. K. et al. WAKMAR2, a long noncoding RNA downregulated in human chronic wounds, modulates keratinocyte motility and production of inflammatory chemokines. J. Invest. Dermatol. 139, 1373–1384 (2019).
Sawaya, A. P. et al. Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5. J. Biol. Chem. 293, 1439–1449 (2018).
Zhang, X. et al. LncRNA MACC1-AS1 sponges multiple miRNAs and RNA-binding protein PTBP1. Oncogenesis 8, 73 (2019).
Li, X. & Xu Landen, N. Evaluation of microRNA therapeutic potential using the mouse in vivo and human ex vivo wound models. Methods Mol. Biol. 2193, 67–75 (2021).
Brandwein, M., Steinberg, D. & Meshner, S. Microbial biofilms and the human skin microbiome. NPJ Biofilms Microbiomes 2, 3 (2016).
Stacy, A., McNally, L., Darch, S. E., Brown, S. P. & Whiteley, M. The biogeography of polymicrobial infection. Nat. Rev. Microbiol. 14, 93–105 (2016).
Fischbach, M. A. & Segre, J. A. Signaling in host-associated microbial communities. Cell 164, 1288–1300 (2016).
Castillo-Juarez, I. et al. Role of quorum sensing in bacterial infections. World J. Clin. Cases 3, 575–598 (2015).
Pouget, C. et al. Biofilms in diabetic foot ulcers: significance and clinical relevance. Microorganisms 8, 1580 (2020).
Tomic-Canic, M., Burgess, J. L., O’Neill, K. E., Strbo, N. & Pastar, I. Skin microbiota and its interplay with wound healing. Am. J. Clin. Dermatol. 21 (Suppl. 1), 36–43 (2020).
Johnson, T. R. et al. The cutaneous microbiome and wounds: new molecular targets to promote wound healing. Int. J. Mol. Sci. 19, 2699 (2018).
Metcalf, D. G. & Bowler, P. G. Biofilm delays wound healing: a review of the evidence. Burns Trauma 1, 5–12 (2013).
Williams, H. et al. Cutaneous Nod2 expression regulates the skin microbiome and wound healing in a murine model. J. Invest. Dermatol. 137, 2427–2436 (2017).
Wolcott, R. D. et al. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair. Regen. 24, 163–174 (2016).
Harrison, O. J. et al. Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science 363, eaat6280 (2019).
Loesche, M. et al. Temporal stability in chronic wound microbiota is associated with poor healing. J. Invest. Dermatol. 137, 237–244 (2017).
Tipton, C. D. et al. Patient genetics is linked to chronic wound microbiome composition and healing. PLoS Pathog. 16, e1008511 (2020).
Bar, J. et al. Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa. Clin. Exp. Dermatol. 46, 1223–1229 (2021).
Kalan, L. R. et al. Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe 25, 641–655 e5 (2019).
Kashem, S. W. et al. Nociceptive sensory fibers drive interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity. Immunity 43, 515–526 (2015).
Pinho-Ribeiro, F. A. et al. Blocking neuronal signaling to immune cells treats streptococcal invasive infection. Cell 173, 1083–1097.e22 (2018).
Cohen, J. A. et al. Cutaneous TRPV1(+) neurons trigger protective innate type 17 anticipatory immunity. Cell 178, 919–932.e14 (2019).
Bagood, M. D. & Isseroff, R. R. TRPV1: role in skin and skin diseases and potential target for improving wound healing. Int. J. Mol. Sci. 22, 6135 (2021).
Kalan, L. et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. mBio 7, e1058-16 (2016).
Hurabielle, C. et al. Immunity to commensal skin fungi promotes psoriasiform skin inflammation. Proc. Natl Acad. Sci. USA 117, 16465–16474 (2020).
Patel, S., Maheshwari, A. & Chandra, A. Biomarkers for wound healing and their evaluation. J. Wound Care 25, 46–55 (2016).
Eaglstein, W. H. & Falanga, V. Chronic wounds. Surg. Clin. North. Am. 77, 689–700 (1997).
Falanga, V. Wound healing and chronic wounds. J. Cutan. Med. Surg. 3 (Suppl. 1), S1-1-5 (1998).
O’Donnell, T. F. Jr & Passman, M. A. Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) — management of venous leg ulcers. introduction. J. Vasc. Surg. 60(2 Suppl.), 1S–2S (2014).
O’Donnell, T. F. Jr et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery (R) and the American Venous Forum. J. Vasc. Surg. 60 (2 Suppl.), 3S–59S (2014).
Browse, N. L. & Burnand, K. G. The cause of venous ulceration. Lancet 2, 243–245 (1982).
Burnand, K. G., Clemenson, G., Whimster, I., Gaunt, J. & Browse, N. L. The effect of sustained venous hypertension on the skin capillaries of the canine hind limb. Br. J. Surg. 69, 41–44 (1982).
Kirsner, R. S., Pardes, J. B., Eaglstein, W. H. & Falanga, V. The clinical spectrum of lipodermatosclerosis. J. Am. Acad. Dermatol. 28, 623–627 (1993).
Morton, L. M. & Phillips, T. J. Wound healing and treating wounds: differential diagnosis and evaluation of chronic wounds. J. Am. Acad. Dermatol. 74, 589–605 (2016). quiz 605–606.
Powers, J. G., Higham, C., Broussard, K. & Phillips, T. J. Wound healing and treating wounds: chronic wound care and management. J. Am. Acad. Dermatol. 74, 607–625; quiz 625–626 (2016).
Armstrong, D. G., Boulton, A. J. M. & Bus, S. A. Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 376, 2367–2375 (2017).
Boulton, A. J., Kirsner, R. S. & Vileikyte, L. Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med. 351, 48–55 (2004).
Ghotaslou, R., Memar, M. Y. & Alizadeh, N. Classification, microbiology and treatment of diabetic foot infections. J. Wound Care 27, 434–441 (2018).
Li, W. W., Carter, M. J., Mashiach, E. & Guthrie, S. D. Vascular assessment of wound healing: a clinical review. Int. Wound J. 14, 460–469 (2017).
Kirsner, R. S. & Vivas, A. C. Lower-extremity ulcers: diagnosis and management. Br. J. Dermatol. 173, 379–390 (2015).
Alvaro-Afonso, F. J. et al. Interobserver reliability of the ankle-brachial index, toe-brachial index and distal pulse palpation in patients with diabetes. Diab Vasc. Dis. Res. 15, 344–347 (2018).
Rayman, G. et al. Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes Metab. Res. Rev. 36 (Suppl. 1), e3283 (2020).
Moore, Z. E. & Patton, D. Risk assessment tools for the prevention of pressure ulcers. Cochrane Database Syst. Rev. 1, CD006471 (2019).
Oliveira, A. L., Moore, Z., Connor, T. O. & Patton, D. Accuracy of ultrasound, thermography and subepidermal moisture in predicting pressure ulcers: a systematic review. J. Wound Care 26, 199–215 (2017).
Gottrup, F. et al. Antimicrobials and non-healing wounds. Evidence, controversies and suggestions-key messages. J. Wound Care 23, 477–478 (2014). 480, 482.
Haalboom, M. et al. Culture results from wound biopsy versus wound swab: does it matter for the assessment of wound infection? Clin. Microbiol. Infect. 25, 629.e7–629.e12 (2019).
Tang, J. C., Vivas, A., Rey, A., Kirsner, R. S. & Romanelli, P. Atypical ulcers: wound biopsy results from a university wound pathology service. Ostomy Wound Manage. 58, 20–22, 24, 26–29 (2012).
Panuncialman, J., Hammerman, S., Carson, P. & Falanga, V. Wound edge biopsy sites in chronic wounds heal rapidly and do not result in delayed overall healing of the wounds. Wound Repair Regen. 18, 21–25 (2010).
Falanga, V., Kirsner, R. S., Eaglstein, W. H., Katz, M. H. & Kerdel, F. A. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet 338, 347–348 (1991).
Baby, D. et al. Calciphylaxis and its diagnosis: a review. J. Fam. Med. Prim. Care 8, 2763–2767 (2019).
Dini, V. et al. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody. Int. J. Low. Extrem. Wounds 6, 108–113 (2007).
Fox, J. D. et al. Adalimumab treatment leads to reduction of tissue tumor necrosis factor-alpha correlated with venous leg ulcer improvement: a pilot study. Int. Wound J. 13, 963–966 (2016).
Ahmed, S., O’Neill, K. D., Hood, A. F., Evan, A. P. & Moe, S. M. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am. J. Kidney Dis. 37, 1267–1276 (2001).
Tardaguila-Garcia, A. et al. Metalloproteinases in chronic and acute wounds: a systematic review and meta-analysis. Wound Repair Regen. 27, 415–420 (2019).
Dini, V. et al. Potential correlation of wound bed score and biomarkers in chronic lower leg wounds: an exploratory study. J. Wound Care 26, S9–S17 (2017).
Stacey, M. C. Biomarker directed chronic wound therapy-a new treatment paradigm. J. Tissue Viability 29, 180–183 (2020).
Boyd, G., Butcher, M., Glover, D. & Kingsley, A. Prevention of non-healing wounds through the prediction of chronicity. J. Wound Care 13, 265–266 (2004).
Gethin, G., Probst, S., Stryja, J., Christiansen, N. & Price, P. Evidence for person-centred care in chronic wound care: a systematic review and recommendations for practice. J. Wound Care 29, S1–S22 (2020).
Candan, C., Nergis, B., Cimilli Duru, S. & Koyuncu, B. Development of a care labelling process for compression stockings based on natural (cotton) fibers. Polymers 13, 2107 (2021).
Lindsay, E. The Lindsay Leg Club Model: a model for evidence-based leg ulcer management. Br. J. Community Nurs. 9 (Suppl. 2), S15–S20 (2004).
Nukada, H. Ischemia and diabetic neuropathy. Handb. Clin. Neurol. 126, 469–487 (2014).
Crews, R. T., King, A. L., Yalla, S. V. & Rosenblatt, N. J. Recent advances and future opportunities to address challenges in offloading diabetic feet: a mini-review. Gerontology 64, 309–317 (2018).
Lim, E., Mordiffi, Z., Chew, H. S. J. & Lopez, V. Using the Braden subscales to assess risk of pressure injuries in adult patients: a retrospective case-control study. Int. Wound J. 16, 665–673 (2019).
Padula, W. V., Chen, Y. H. & Santamaria, N. Five-layer border dressings as part of a quality improvement bundle to prevent pressure injuries in US skilled nursing facilities and Australian nursing homes: a cost-effectiveness analysis. Int. Wound J. 16, 1263–1272 (2019).
Phillips, C. J. et al. Estimating the costs associated with the management of patients with chronic wounds using linked routine data. Int. Wound J. 13, 1193–1197 (2016).
Guest, J. F., Fuller, G. W. & Vowden, P. Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018: update from 2012/2013. BMJ Open 10, e045253 (2020).
Obagi, Z., Damiani, G., Grada, A. & Falanga, V. Principles of wound dressings: a review. Surg. Technol. Int. 35, 50–57 (2019).
Herrick, S. E. et al. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am. J. Pathol. 141, 1085–1095 (1992).
Boulton, A. J., Meneses, P. & Ennis, W. J. Diabetic foot ulcers: a framework for prevention and care. Wound Repair Regen. 7, 7–16 (1999).
Falanga, V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 8, 347–352 (2000).
Ayello, E. A. et al. TIME heals all wounds. Nursing 34, 36–41 quiz, 41-2 (2004).
Schultz, G. S. et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 11 (Suppl. 1), S1–S28 (2003).
Sibbald, R. G. et al. Wound bed preparation 2021. Adv. Skin. Wound Care 34, 183–195 (2021).
Falanga, V. et al. Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial. Wound Repair Regen. 7, 208–213 (1999).
Jull, A., Waters, J. & Arroll, B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet 359, 1550–1554 (2002).
& Falanga, V. et al. Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage. 54 (Suppl.), 2–15 (2008).
Bucalo, B., Eaglstein, W. H. & Falanga, V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen. 1, 181–186 (1993).
Katz, M. H., Alvarez, A. F., Kirsner, R. S., Eaglstein, W. H. & Falanga, V. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J. Am. Acad. Dermatol. 25, 1054–1058 (1991).
Langer, V., Bhandari, P. S., Rajagopalan, S. & Mukherjee, M. K. Negative pressure wound therapy as an adjunct in healing of chronic wounds. Int. Wound J. 12, 436–442 (2015).
Seidel, D. et al. Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT. BMJ Open 10, e026345 (2020).
Wang, G. et al. Bacteria induce skin regeneration via IL-1beta signaling. Cell Host Microbe 29, 777–791.e6 (2021).
Karinja, S. J. & Spector, J. A. Treatment of infected wounds in the age of antimicrobial resistance: contemporary alternative therapeutic options. Plast. Reconstr. Surg. 142, 1082–1092 (2018).
Gareau, M. G., Sherman, P. M. & Walker, W. A. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 7, 503–514 (2010).
Fijan, S. et al. Efficacy of using probiotics with antagonistic activity against pathogens of wound infections: an integrative review of literature. Biomed. Res. Int. 2019, 7585486 (2019).
Mohseni, S. et al. The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Diabetes Metab. Res. Rev. 34, e2970 (2018).
De Pessemier, B. et al. Gut–skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms 9, 353 (2021).
Falanga, V. Occlusive wound dressings. Why, when, which? Arch. Dermatol. 124, 872–877 (1988).
Barros Almeida, I. et al. Smart dressings for wound healing: a review. Adv. Skin. Wound Care 34, 1–8 (2021).
Falanga, V. et al. Topically applied recombinant tissue plasminogen activator for the treatment of venous ulcers. Preliminary report. Dermatol. Surg. 22, 643–644 (1996).
Steed, D. L. et al. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15, 1598–1604 (1992).
Steed, D. L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J. Vasc. Surg. 21, 71–78 discussion 79-81 (1995).
Rees, R. S., Robson, M. C., Smiell, J. M. & Perry, B. H. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen. 7, 141–147 (1999).
Smiell, J. M. et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 7, 335–346 (1999).
Wieman, T. J. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Am. J. Surg. 176 (2A Suppl.), 74S–79S (1998).
Steed, D. L., Donohoe, D., Webster, M. W. & Lindsley, L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J. Am. Coll. Surg. 183, 61–64 (1996).
Falanga, V. The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cell Mol. Dis. 32, 88–94 (2004).
Yamakawa, S. & Hayashida, K. Advances in surgical applications of growth factors for wound healing. Burns Trauma 7, 10 (2019).
Falanga, V. et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch. Dermatol. 134, 293–300 (1998).
Falanga, V. & Sabolinski, M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 7, 201–207 (1999).
Veves, A., Falanga, V., Armstrong, D. G. & Sabolinski, M. L. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24, 290–295 (2001).
MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 445, 874–880 (2007).
Phillips, T. J. et al. The longevity of a bilayered skin substitute after application to venous ulcers. Arch. Dermatol. 138, 1079–1081 (2002).
Falanga, V. et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 13, 1299–1312 (2007).
Harding, K., Sumner, M. & Cardinal, M. A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers. Int. Wound J. 10, 132–137 (2013).
Marston, W. A., Hanft, J., Norwood, P. & Pollak, R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26, 1701–1705 (2003).
Mostow, E. N. et al. Effectiveness of an extracellular matrix graft (OASIS wound matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J. Vasc. Surg. 41, 837–843 (2005).
Omar, A. A., Mavor, A. I., Jones, A. M. & Homer-Vanniasinkam, S. Treatment of venous leg ulcers with Dermagraft. Eur. J. Vasc. Endovasc. Surg. 27, 666–672 (2004).
Bosanquet, D. C. et al. Development and validation of a gene expression test to identify hard-to-heal chronic venous leg ulcers. Br. J. Surg. 106, 1035–1042 (2019).
Rahim, K. et al. Bacterial contribution in chronicity of wounds. Microb. Ecol. 73, 710–721 (2017).
Jeffcoate, W. J. et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol. Assess. 13, 1–86 iii–iv (2009).
Grey, J. E., Leaper, D. & Harding, K. How to measure success in treating chronic leg ulcers. BMJ 338, b1434 (2009).
Franks, P. J. & Moffatt, C. J. Who suffers most from leg ulceration? J. Wound Care 7, 383–385 (1998).
Zhou, K. & Jia, P. Depressive symptoms in patients with wounds: a cross-sectional study. Wound Repair Regen. 24, 1059–1065 (2016).
Kapp, S., Miller, C. & Santamaria, N. The quality of life of people who have chronic wounds and who self-treat. J. Clin. Nurs. 27, 182–192 (2018).
Kapp, S. & Santamaria, N. The financial and quality-of-life cost to patients living with a chronic wound in the community. Int. Wound J. 14, 1108–1119 (2017).
Fayne, R. A., Borda, L. J., Egger, A. N. & Tomic-Canic, M. The potential impact of social genomics on wound healing. Adv. Wound Care 9, 325–331 (2020).
Sen, C. K. & Roy, S. Sociogenomic approach to wound care: a new patient-centered paradigm. Adv. Wound Care 8, 523–526 (2019).
Ware, J. E. Jr & Sherbourne, C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30, 473–483 (1992).
EuroQol, G. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16, 199–208 (1990).
Price, P. & Harding, K. Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds of the lower limb. Int. Wound J. 1, 10–17 (2004).
Martinez-Gonzalez, D. et al. Adaptation and validation of the diabetic foot ulcer scale-short form in Spanish subjects. J. Clin. Med. 9, 2497 (2020).
Moore, Z. et al. Exploring the concept of a team approach to wound care: managing wounds as a team. J. Wound Care 23 (Suppl. 5b), S1–S38 (2014).
Kapp, S. & Santamaria, N. How and why patients self-treat chronic wounds. Int. Wound J. 14, 1269–1275 (2017).
Miller, C. & Kapp, S. Informal carers and wound management: an integrative literature review. J. Wound Care 24, 489–490 (2015).
Kapp, S. & Santamaria, N. Chronic wounds should be one of Australia’s national health priority areas. Aust. Health Rev. 39, 600–602 (2015).
Hellmann, J., Tang, Y. & Spite, M. Proresolving lipid mediators and diabetic wound healing. Curr. Opin. Endocrinol. Diabetes Obes. 19, 104–108 (2012).
Pils, V., Terlecki-Zaniewicz, L., Schosserer, M., Grillari, J. & Lammermann, I. The role of lipid-based signalling in wound healing and senescence. Mech. Ageing Dev. 198, 111527 (2021).
Hu, M. S., Borrelli, M. R., Lorenz, H. P., Longaker, M. T. & Wan, D. C. Mesenchymal stromal cells and cutaneous wound healing: a comprehensive review of the background, role, and therapeutic potential. Stem Cell Int. 2018, 6901983 (2018).
Kucharzewski, M. et al. Novel trends in application of stem cells in skin wound healing. Eur. J. Pharmacol. 843, 307–315 (2019).
Otero-Vinas, M. & Falanga, V. Mesenchymal stem cells in chronic wounds: the spectrum from basic to advanced therapy. Adv. Wound Care 5, 149–163 (2016).
Li, P. & Guo, X. A review: therapeutic potential of adipose-derived stem cells in cutaneous wound healing and regeneration. Stem Cell Res. Ther. 9, 302 (2018).
van Dongen, J. A., Harmsen, M. C., van der Lei, B. & Stevens, H. P. Augmentation of dermal wound healing by adipose tissue-derived stromal cells (ASC). Bioengineering 5, 91 (2018).
Brockmann, I. et al. Skin-derived stem cells for wound treatment using cultured epidermal autografts: clinical applications and challenges. Stem Cell Int. 2018, 4623615 (2018).
Gonzales, K. A. U. & Fuchs, E. Skin and its regenerative powers: an alliance between stem cells and their niche. Dev. Cell 43, 387–401 (2017).
Himal, I., Goyal, U. & Ta, M. Evaluating Wharton’s jelly-derived mesenchymal stem cell’s survival, migration, and expression of wound repair markers under conditions of ischemia-like stress. Stem Cell Int. 2017, 5259849 (2017).
Lin, X. et al. An in vitro priming step increases the expression of numerous epidermal growth and migration mediators in a tissue-engineering construct. J. Tissue Eng. Regen. Med. 11, 713–723 (2017).
Magne, B., Lataillade, J. J. & Trouillas, M. Mesenchymal stromal cell preconditioning: the next step toward a customized treatment for severe burn. Stem Cell Dev. 27, 1385–1405 (2018).
Xu, W., Xu, R., Li, Z., Wang, Y. & Hu, R. Hypoxia changes chemotaxis behaviour of mesenchymal stem cells via HIF-1alpha signalling. J. Cell Mol. Med. 23, 1899–1907 (2019).
Yang, H. Y. et al. Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. Stem Cell Transl. Med. 9, 1353–1364 (2020).
Ariyanti, A. D. et al. Salidroside-pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under hyperglycemia. Stem Cell Transl. Med. 8, 404–414 (2019).
Larsen, L. et al. Combination therapy of autologous adipose mesenchymal stem cell-enriched, high-density lipoaspirate and topical timolol for healing chronic wounds. J. Tissue Eng. Regen. Med. 12, 186–190 (2018).
Yoshikawa, T. et al. Wound therapy by marrow mesenchymal cell transplantation. Plast. Reconstr. Surg. 121, 860–877 (2008).
Dash, N. R., Dash, S. N., Routray, P., Mohapatra, S. & Mohapatra, P. C. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 12, 359–366 (2009).
Falanga, V. et al. Autologous cultured bone marrow-derived mesenchymal stem cells in a fibrin spray to treat venous ulcers: a randomized controlled double-blind pilot study. Surg. Technol. Int. 40, 47–54 (2022).
Ferreira, A. D. F. & Gomes, D. A. Stem cell extracellular vesicles in skin repair. Bioengineering 6, 4 (2018).
McBride, J. D., Rodriguez-Menocal, L. & Badiavas, E. V. Extracellular vesicles as biomarkers and therapeutics in dermatology: a focus on exosomes. J. Invest. Dermatol. 137, 1622–1629 (2017).
Phinney, D. G. & Pittenger, M. F. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cell 35, 851–858 (2017).
Roefs, M. T., Sluijter, J. P. G. & Vader, P. Extracellular vesicle-associated proteins in tissue repair. Trends Cell Biol. 30, 990–1013 (2020).
Sung, B. H., Parent, C. A. & Weaver, A. M. Extracellular vesicles: critical players during cell migration. Dev. Cell 56, 1861–1874 (2021).
Bailey, A. J. M. et al. MSC-derived extracellular vesicles to heal diabetic wounds: a systematic review and meta-analysis of preclinical animal studies. Stem Cell Rev. Rep. 18, 968–979 (2022).
Margolis, D. J., Gross, E. A., Wood, C. R. & Lazarus, G. S. Planimetric rate of healing in venous ulcers of the leg treated with pressure bandage and hydrocolloid dressing. J. Am. Acad. Dermatol. 28, 418–421 (1993).
Tallman, P., Muscare, E., Carson, P., Eaglstein, W. H. & Falanga, V. Initial rate of healing predicts complete healing of venous ulcers. Arch. Dermatol. 133, 1231–1234 (1997).
Falanga, V. Measurements in wound healing. Int. J. Low. Extrem. Wounds 7, 9–11 (2008).
Otero, M., Lin, X., MacLauchlan, S., Carson, P. & Falanga, V. Dermal fibroblasts from chronic wounds exhibit paradoxically enhanced proliferative and migratory activities that may be related to the non-canonical Wnt signaling pathway. Surg. Technol. Int. 39, 59–66 (2021).
Panuncialman, J. & Falanga, V. The science of wound bed preparation. Surg. Clin. North Am. 89, 611–626 (2009).
The authors declare no competing interests.
Peer review information
Nature Reviews Disease Primers thanks R. D. Galiano, L. Téot and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Cochrane Wounds systematic reviews database: https://wounds.cochrane.org/news/reviews
Diabetic Foot Consortium: http://diabeticfootconsortium.org/
Lindsay Leg Club Foundation: https://www.legclub.org/
United States Diabetes Surveillance System: https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html
About this article
Cite this article
Falanga, V., Isseroff, R.R., Soulika, A.M. et al. Chronic wounds. Nat Rev Dis Primers 8, 50 (2022). https://doi.org/10.1038/s41572-022-00377-3